Overview
Camcevi SurGuard 3 Safety Needle is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced prostate cancer. The prescription includes a prefilled syringe called the SurGuard 3 Safety Needle. Camcevi is also known by its drug name, leuprolide.

Camcevi SurGuard 3 Safety Needle belongs to a class of drugs called gonadotropin-releasing hormone (GnRH) agonists. It works by lowering testosterone levels in the body, which helps slow or stop the growth of prostate cancer cells. 

How do I take it?
Prescribing information states that Camcevi SurGuard 3 Safety Needle is given as a subcutaneous (under the skin) injection using a prefilled syringe with a SurGuard 3 Safety Needle. It is typically administered once every six months. Camcevi SurGuard 3 Safety Needle  should be administered by a healthcare provider and used exactly as prescribed.

Side effects
Common side effects of Camcevi SurGuard 3 Safety Needle include hot flushes, hypertension (high blood pressure), injection site reactions, fatigue, upper respiratory tract infections, muscle and bone pain, pain in the arms or legs, arthralgia (joint pain), micturition urgency or  nocturia (urgent or frequent urination), and dizziness.

Rare but serious side effects may include worsening of prostate cancer symptoms during the first few weeks of treatment (tumor flare), hyperglycemia (high blood sugar), new or worsening diabetes, heart problems such as heart attack and stroke, prolonged QT interval (a heart rhythm condition), seizures, and severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. Camcevi SurGuard 3 Safety Needle may also cause harm to an unborn baby and affect fertility.

For more information about this treatment, visit:

Label: Camcevi — Leuprolide Injection, Emulsion — DailyMed